Progressive Labs, Osteo-Mins PM with D, 240 Capsules
UPC Code: 351821011257
Notice: Progressive Labs is currently updating their product labels. Some products have already transitioned to the new design while others are still being updated. During this period, you may receive packaging with either the previous or updated design.
Description
Bioavailable calcium is essential for bone health; however, bone is complex living tissue that, like other body tissues, has a wide range of nutritional needs. The Osteo-Mins formulas were developed and formulated by Jonathan V. Wright, M.D., author of Nutrition and Healing. In addition to calcium these formulas supply strontium, boron, silicon and other vitamins and trace minerals researched to support bone growth. The Osteo-Mins AM formula containing strontium, zinc, selenium, copper, manganese, molybdenum, boron and silicon is taken in the morning. The Osteo-Mins PM formula containing calcium, magnesium, vitamin D (or vitamins D and K) are taken at bedtime.
Many researchers feel when these nutrients are taken at different times during the day, assimilation of all nutrients is improved.
Packaging
240 Capsules
Suggested Use
Eight capsules daily in the PM, or as directed by a health care professional.
About Progressive Labs
To create these top-of-the-line products, we utilize exact ingredient sources and forms applied in clinical research. We have never made products with raw materials sourced from bargain suppliers, and we won’t. We select American, European, and quality-verified suppliers of key raw materials, and we always will.
Safety
Please consult your health care provider if currently under care or treatment or for pregnancy, nursing, and child safety instructions. Keep out of reach of children. Do not exceed recommended serving. See product packaging for additional safety information.
Disclaimer
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.